Clinical Trial Update: A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial updating pregabalin as an augmentation in obsessive-compulsive disorder patients refractory to SSRIs has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: McMaster University | Conditions: Obsessive-Compulsive Disorder | Phase 4 | Status: COMPLETED